ESGCT 2025 | BioAgilytix 

BioAgilytix is the trusted partner for global bioanalytical services throughout every phase of the drug development process. We provide custom, fit-for-purpose, and comprehensive bioanalytical support for your program needs. With over a decade of gene and cell therapy experience, we have worked with over a hundred partners to build the right bioanalytical package based on the current regulatory expectations.

We provide the complete package of pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. Our labs provide immunoassay, cell-based assay, molecular biology, and LC/MS assay development, validation, and sample testing, eliminating the need for multiple providers, ensuring efficient data delivery for your therapeutic study.

The ESGCT conference is an annual event that brings together experts in the field of gene and cell therapy. ESGCT stands for the European Society of Gene and Cell Therapy, and its mission is to promote research, education, and clinical translation of gene and cell therapies. The conference covers a wide range of topics related to gene and cell therapy, including basic science, clinical trials, and regulatory issues. Attendees can expect to hear from leading researchers in the field, exchange ideas, and learn about new developments in gene and cell therapy. The conference is a great opportunity for scientists, clinicians, and industry professionals to network and collaborate on new projects. And you can learn more on their website.

ESGCT– 32nd Annual Congress

Presentation by BioAgilytix

Customized approaches to support your gene or cell therapy bioanalytical needs

Schedule a meeting with our experts on site

About the event

Schedule a meeting with our experts on site